The week American Association of Cancer Research (AACR) kicks off its annual meeting in Chicago, and we’ll be bringing you the latest announcements. News In this weeks news: Health News – Metformin May Improve Pancreatic Cancer Prognosis in Patients With Diabetes Medical Xpress: The protein survivin could be a useful biomarker for pancreatic cancer Clovis […]
Latest Pancreatic Cancer News & Journal Articles Read More »
News In this weeks news: Threshold’s phase 2b trial of TH-302 in patients with pancreatic cancer meets primary endpoint Biotechnology company Threshold Pharmaceuticals, Inc. announced that its 214 patient randomized controlled phase 2b clinical trial evaluating the efficacy and safety of two doses of the investigational agent TH-302 in combination with gemcitabine compared to gemcitabine
Latest Pancreatic Cancer News and Articles Read More »
When Gleevec, the very first targeted therapeutic came out, there was a mad rush in the pharmaceutical industry to mine the genome for potential “magic bullet” targets. In Gleevec’s case, it was able to inhibit the BCR-ABL fusion kinase, and turn a deadly disease into a manageable chronic condition. But with a disease as complex
Stunning News In Pancreatic Cancer Research Read More »
After my recent post on the current state of pancreatic cancer research, a reader got me wondering if we are indeed making any measureable progress towards understanding and treating pancreatic cancer. My first thought was that a simple year-by-year count of the papers on the subject would give me a crude measure. I’d been itching
Pancreatic Cancer: Are We Making Any Progress? Read More »
